UBS Group Reiterates “Neutral” Rating for Novartis (NYSE:NVS)

Novartis (NYSE:NVS – Get Free Report)‘s stock had its “neutral” rating restated by analysts at UBS Group in a report released on Thursday, MarketBeat Ratings reports. Other equities analysts also recently issued research reports about the stock. Erste Group Bank reissued a “hold” rating on shares of Novartis in a report on Tuesday, November 19th. […]

Leave a Reply

Your email address will not be published.

Previous post Susquehanna Lowers Lyft (NASDAQ:LYFT) Price Target to $15.00
Next post Wells Fargo & Company Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to Overweight